The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zarochentseva N.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Dzhidzhikhiia L.K.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Vulvar intraepithelial neoplasia: current approach to the problem

Authors:

Zarochentseva N.V., Dzhidzhikhiia L.K.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2020;20(1): 44‑53

DOI: 10.17116/rosakush20202001144

Views: 29286

Downloaded: 557

Download PDF (RU)
Contact the author
Table of contents

VULVAR INTRAEPITHELIAL NEOPLASIA: CURRENT APPROACH TO THE PROBLEM
VULVAR INTRAEPITHELIAL NEOPLASIA: CURRENT APPROACH TO THE PROBLEM

To cite this article:

Zarochentseva NV, Dzhidzhikhiia LK. Vulvar intraepithelial neoplasia: current approach to the problem. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(1):44‑53. (In Russ.)
https://doi.org/10.17116/rosakush20202001144

Подписка 2025-2 (Russian Bulletin of Obstetrician-Gynecologist)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Effi­cacy and safety of choline alfo­scerate in the preventive therapy of deme­ntia in elde­rly patients with Mild Cognitive Impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):92-99
Algo­rithms for the diagnosis and treatment of cognitive impairment and dysphagia in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):100-107
Mini­mally inva­sive inte­rventions for complications asso­ciated with intra-abdominal calculi after lapa­roscopic cholecystectomy. Piro­gov Russian Journal of Surgery. 2024;(5):14-20
Use of systemic steroids in hospitalized patients with COVID-19. Russian Journal of Preventive Medi­cine. 2024;(5):75-80
Our expe­rience in the treatment of congenital nasal median hete­rotopias in children and an overview of various treatment tactics. Russian Bulletin of Otorhinolaryngology. 2024;(2):28-32
Clinical and anatomical rationale for the effe­ctiveness of treatment of phle­gmon of the floor of the oral cavity and deep cellular spaces of the neck complicated with sepsis. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(2):19-25
Chro­nic rhinosinusitis with nasal polyps as the first stage in the deve­lopment of eosi­nophilic granulomatosis with polya­ngiitis. Russian Rhinology. 2024;(2):157-166
B vita­mins and diseases of the peri­pheral nervous system. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):75-82
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Expe­rience with the use of risdiplam in a fami­lial case of spinal muscular atro­phy 5q in patients with a homo­zygous dele­tion of the SMN1 gene and the same copy number of the SMN2 gene. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):138-141

This analytical review presents the published findings of the resent research studies that describe the problem of pre-malignant diseases and vulval cancer. The existing classifications of these diseases are presented. There are described epidemiology, modern viewpoints on etiology and pathogenesis, peculiar features of diagnostics, conservative (medical), destructive (laser CO2-vaporization, photodynamic therapy), and surgical treatment of classic vulvar intraepithelial neoplasia associated with papillomavirus infection and differentiated vulvar intraepithelial neoplasia that is not associated with human papilloma virus. The importance of preventive vaccination against human papilloma viruses of highly oncogenic types is stressed in order to prevent the development of cancer of female genital organs of different localizations, including vulval cancer.

Keywords:

classic vulvar intraepithelial neoplasia associated with papillomavirus infection
differentiated vulvar intraepithelial neoplasia
etiopathogenesis
diagnostics
treatment
vulval cancer
preventive vaccination against human papilloma viruses

Authors:

Zarochentseva N.V.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

Dzhidzhikhiia L.K.

Moskovskiĭ oblastnoĭ NII akusherstva i ginekologii

List of references:

  1. Apgar BS, Brotsman GL, Shpitser M, Ferentsi A. Clinical colposcopy. Trans. From English. Ed V.N. Prilepskaya. Prakticheskaya meditsina. 2012;492. (In Russ.)
  2. Cherenkov VG, Alexandrova IV, Shpenkova AA. Vulva cancer: pathogenetic options, diagnostics, treatment, plastic surgery. Opukholi zhenskoi reproduktivnoi sistemy. 2010;4:78-82. (In Russ.)
  3. Sznurkowski JJ, Zawrocki A, Emerich J. Vulvar cancer: modern approaches to treatment. Meditsinskie aspekty zdorov’ya zhenshchiny. 2011;5:65-70. (In Russ.)
  4. Buttmann-Schweiger N., Klug SJ, Luyten A, Holleczek B, Heitz F, du Bois A, Kraywinkel K. Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999- 2011. A population-based cancer registry analysis. PLoS ONE. 2015;10:5.
  5. Lai J, Elleray R, Nordin A, Hirschowitz L, Rous B, Gildea C, Poole J. Vulval cancer incidence, mortality and survival in England: age-related trends. Gynaecol Oncol BJOG. 2014;121:728-738.
  6. Chissov VI, Kaprin AD, Starinskiy VV. Malignant neoplasms in Russia in 2011 (morbidity and mortality). FGU «Moscovskii nauchno-issledovatel’skii institute im. P.A. Gertsena Minzdravsotsrazvitiya Rossii». 2013. (In Russ.)
  7. Zharov AV, Vazhenin AV. Optimization of treatment of patients with vulvar cancer. Chelyabinsk. 2005;131. (In Russ.)
  8. Chulkova OV, Novikova EG, Sokolov VV, Chulkova EA. Diagnostics and treatment of background and precancerous diseases of the vulva. Prakticheskaya onkologiya. 2006;7:4:197-204. (In Russ.)
  9. Singer A, Ashfak Kh. Precancerous diseases of the cervix, vagina, vulva. Diagnostics and treatment. Ed. Rogovskaya SI. Moscow: GEOTAR-Media, 2017;312. (In Russ.)
  10. Wilkinson EG, Stone KI. Diseases of the vulva. Clinical guideline. Transl.from English. Moscow: Binom, 2009;248. (In Russ.)
  11. Arulkumaran S, Regan L, Papageorghiou A, Monga A, Farquharson D. Oxford Desk Reference: Obstetrics and Gynaecology. 2011; 682-685.
  12. Wilkinson EJ, Kneale BL, Lynch FW. Report of the ISSVD terminology committee: VIN. J Reprod Med. 1986;31:973-974.
  13. Sideri M, Jones RW, Wilkinson EJ, Preti M, Heller DS, Scurry J, Haefner H, Neill S. Squamous vulvar intraepithelial neoplasia: 2004 modified terminology, ISSVD vulvar oncology subcommittee. J Reprod Med. 2005;50:807-810.
  14. De Vuijst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a metaanalysis. Int J Cancer. 2009;124:1626-1636.
  15. Willem I. van der Meijden, Michael J Boffa, Bram ter Harmsel, Gudula Kirtschig, Fiona Lewis, Micheline Moyal-Barracco, George-Sorin Tiplica, Jackie Sherrard. European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2017;31:6:925-941.
  16. Joura EA, Lösch A, Haider-Angeler MG, Breitenecker G, Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. 2000;45:613-615.
  17. Van de Nieuwenhof HP, Massuger LF, van der Avoort IA, Bekkers RL, Casparie M, Abma W, van Kempen LC, de Hullu JA. Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age. Eur J Cancer. 2009;45:851-856.
  18. Baandrup L, Varbo A, Munk C, Johansen C, Frisch M, Kjaer SK. In situ and invasive squamous cell carcinoma of the vulva in Denmark 1978-2007 — a nationwide population-based study. Gynecol Oncol. 2011;122:45-49.
  19. Hampl M, Sarajuuri H, Wentzensen N, Bender HG, Kueppers V. Effect of human papillomavirus vaccines on vulvar, vaginal and anal intraepithelial lesions and vulvar cancer. Obstetr Gynecol. 2006; 108:106:1361-1368.
  20. Yang EJ, Kong CS, Longacre TA. Vulvar and Anal Intraepithelial Neoplasia: Terminology, Diagnosis, and Ancillary Studie. Adv Anat Pathol. 2017;24:3:136-150.
  21. Wallbillich JJ, Rhodes HE, Milbourne AM. Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence. Gynecol Oncol. 2012;127:2:312-315.
  22. GLOBOCAN 2010. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in World. Summary Report 2010. Accessed on 09/09/2012.
  23. Van Esch EM, Welters MJ, Jordanova ES, Trimbos JB, van der Burg SH, van Poelgeest MI. Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy. Expert Rev Vaccines. 2012; 11:7:821-840.
  24. De Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, Joura EA, Maldonado P, Laco J, Bravo IG, Vidal A, Guimerà N, Cross P, Wain GV, Petry KU, Mariani L, Bergeron C, Mandys V, Sica AR, Félix A, Usubutun A, Seoud M, Hernández-Suárez G, Nowakowski AM, Wilson G, Dalstein V, Hampl M, Kasamatsu ES, Lombardi LE, Tinoco L, Alvarado-Cabrero I, Perrotta M, Bhatla N, Agorastos T, Lynch CF, Goodman MT, Shin HR, Viarheichyk H, Jach R, Cruz MO, Velasco J, Molina C, Bornstein J, Ferrera A, Domingo EJ, Chou CY, Banjo AF, Castellsagué X, Pawlita M, Lloveras B, Quint WG, Muñoz N, Bosch FX; HPV VVAP study group. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49:528-535.
  25. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-428.
  26. Bourgault Villada I, Moyal Barracco M, Ziol M, Chaboissier A, Barget N, Berville S, Paniel B, Jullian E, Clerici T, Maillère B, Guillet JG. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses. Cancer Res. 2004;64:8761-8766.
  27. Gul N, Ganesan R, Luesley DM. Characterizing T-cell response in low-grade and high-grade vulval intraepithelial neoplasia, study of CD3, CD4 and CD8 expressions. Gynecol Oncol. 2004;94:48-53.
  28. Santegoets LA, van Seters M, Heijmans-Antonissen C, Kleinjan A, van Beurden M, Ewing PC, Kühne LC, Beckmann I, Burger CW, Helmerhorst TJ, Blok LJ. Reduced local immunity in HPV-related VIN: expression of chemokines and involvement of immunocompetent cells. Int J Cancer. 2008;123:616-622.
  29. Singh K, Yeo Y, Honest H, Ganesan R, Luesley D. Antigen processing and correlation with immunological response in vulval intraepithelial neoplasia — a study of CD1a, CD54 and LN3 expression. Gynecol Oncol. 2006;102:489-492.
  30. van Seters M, Beckmann I, Heijmans-Antonissen C, van Beurden M, Ewing PC, Zijlstra FJ, Helmerhorst TJ, KleinJan A. Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia. Cancer Res. 2008;68:6617-6622.
  31. Meeuwis KA, van Rossum MM, van de Kerkhof PC, Hoitsma AJ, Massuger LF, de Hullu JA. Skin cancer and (pre)malignancies of the female genital tract in renal transplant recipients. Transpl Int. 2010;23:191-199.
  32. Rufforny I, Wilkinson EJ, Liu C, Zhu H, Buteral M, Massoll NA. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma. J Low Genit Tract Dis. 2005;9:108-113.
  33. van der Avoort IA, Shirango H, Hoevenaars BM, Grefte JM, de Hullu JA, de Wilde PC, Bulten J, Melchers WJ, Massuger LF. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways. Int J Gynecol Pathol. 2006;25:22-29.
  34. Hoevenaars BM, van der Avoort IA, de Wilde PC, Massuger LF, Melchers WJ, de Hullu JA, Bulten J. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma. Int J Cancer. 2008;123:12:2767-2773.
  35. Santegoets LA, van Baars R, Terlou A, Heijmans-Antonissen C, Swagemakers SM, van der Spek PJ, Ewing PC, van Beurden M, van der Meijden WI, Helmerhorst TJ, Blok LJ. Different DNA damage and cell cycle checkpoint control in low- and high-risk human papillomavirus infections of the vulva. Int J Cancer. 2012;130:2874-2885.
  36. Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 2001;20:7874-7887.
  37. Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 2001;20:7888-7898.
  38. Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, Puig-Tintoré LM, Ordi J Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol. 2004;23:206-214.
  39. O’Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8-15.
  40. Vasil’eva LN. Benign diseases of the vulva and vagina. Uchebno-metodicheskoe posobie. Minsk, Belarus’. 2012;29. (In Russ.)
  41. Pushkarev VA, Mazitov IM. Cancer of the vulva. Meditsinskii vestnik Bashkortostana. 2013;8:1:123-132. (In Russ.)
  42. Lawrie TA, Nordin A, Chakrabarti M, Bryant A, Kaushik S, Pepas L. Medical and surgical treatments for usual-type vulval intraepithelial neoplasia (uVIN). Cochrane library. 2016.
  43. De Witte CJ, van de Sande AJ, van Beekhuizen HJ, Koeneman MM, Kruse AJ, Gerestein CG. Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review. Gynecol Oncol. 2015;139: 2:377-384.
  44. Van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, Kagie MJ, Meijer CJ, Aaronson NK, Kleinjan A, Heijmans-Antonissen C, Zijlstra FJ, Burger MP, Helmerhorst TJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med. 2008;358:1465-1473.
  45. Gentile M, Bianchi P, Sesti F, Sopracordevole F, Biamonti A, Scirpa P, Schimberni M, Cozza G, Marziani R, Di Martino G, Catalano A, Milazzo GN, Zinna M, Caserta D, Frega A. Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN2/3. Eur Rev Med Pharmacol Sci. 2014;18:19:2949-2952.
  46. Zharov AV. Optimization of treatment of patients with background processes and precancerous vulva. Perm’. 2012;68. (In Russ.)
  47. Jones RW, Rowan DM, Stewart AW. Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women. Obstet Gynecol. 2005;106:1319-1326.
  48. Husseinzadeh N, Recinto C. Frequency of invasive cancer in surgically excised vulvar lesions with intraepithelial neoplasia (VIN3) Gynecol Oncol. 1999;73:119-120.
  49. Polterauer S, Catharina Dressler A, Grimm C, Seebacher V, Tempfer C, Reinthaller A, Hefler L. Accuracy of preoperative vulva biopsy and the outcome of surgery in vulvar intraepithelial neoplasia 2 and 3. Int J Gynecol Pathol. 2009;28:559-562.
  50. Powell LC, Dinh TV, Rajaraman S, Hannigan EV, Dillard EA Jr, Yandell RB, To T. Carcinoma in situ of the vulva. A clinicopathologic study of 50 cases. J Reprod Med. 1986;31:808-814.
  51. Van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005;97:645-651.
  52. Modesitt SC, Waters AB, Walton L, Fowler WC, Van Le L. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol. 1998;92:962-966.
  53. Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100:271-275.
  54. Penna C, Fallani MG, Fambrini M, Zipoli E, Marchionni M. CO2 laser surgery for vulvar intraepithelial neoplasia. Excisional, destructive and combined techniques. J Reprod Med. 2002;47:913-918.
  55. Leufflen L, Baermann P Jr, Rauch P, Routiot T, Bezdetnava L, Guillemin F, Desandes E, Marchal F. Treatment of vulvar intraepithelial neoplasia with CO2 laser vaporization and excision surgery. J Low Genit Tract Dis. 2013;17:4:446-451.
  56. Preti M, Scurry J, Marchitelli CE, Micheletti L. Vulvar intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2014;28: 7:1051-1062.
  57. Jorma Paavonen. Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia. Future Medicine. 2008;325-328.
  58. Saraiya M, Unger E, Thompson T, Lynch C, Hernandez B, Goodman M. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. J National Cancer Institute. 2015;107:6:1-12.
  59. Buchanan TR, Graybill WS, Pierce JY. Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines. Hum Vaccines Immunother. 2016;12:6:1352-1356.
  60. Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2012;344:e1401. https://doi.org/10.1136/bmj.e1401
  61. Stacey Bryan, Cynthia Barbara, Jane Thomasand Adeola Olaitan HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review. BMC Women’s Health. 2019;19:3.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.